ATE315647T1 - Interleukin -18 mutantenproteine, deren herstellung und verwendung - Google Patents
Interleukin -18 mutantenproteine, deren herstellung und verwendungInfo
- Publication number
- ATE315647T1 ATE315647T1 AT02758668T AT02758668T ATE315647T1 AT E315647 T1 ATE315647 T1 AT E315647T1 AT 02758668 T AT02758668 T AT 02758668T AT 02758668 T AT02758668 T AT 02758668T AT E315647 T1 ATE315647 T1 AT E315647T1
- Authority
- AT
- Austria
- Prior art keywords
- interleukin
- production
- mutant proteins
- mutant
- proteins
- Prior art date
Links
- 102000003810 Interleukin-18 Human genes 0.000 title abstract 3
- 108090000171 Interleukin-18 Proteins 0.000 title abstract 3
- 102000008300 Mutant Proteins Human genes 0.000 title 1
- 108010021466 Mutant Proteins Proteins 0.000 title 1
- 102100035017 Interleukin-18-binding protein Human genes 0.000 abstract 1
- 101710205006 Interleukin-18-binding protein Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27432701P | 2001-03-08 | 2001-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE315647T1 true ATE315647T1 (de) | 2006-02-15 |
Family
ID=23047735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02758668T ATE315647T1 (de) | 2001-03-08 | 2002-03-08 | Interleukin -18 mutantenproteine, deren herstellung und verwendung |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7524488B2 (de) |
| EP (1) | EP1392830B1 (de) |
| JP (1) | JP2004530432A (de) |
| KR (1) | KR100862136B1 (de) |
| CN (1) | CN100503829C (de) |
| AT (1) | ATE315647T1 (de) |
| AU (1) | AU2002324249B2 (de) |
| BR (1) | BRPI0207933B8 (de) |
| CA (1) | CA2438851C (de) |
| DE (1) | DE60208692T2 (de) |
| DK (1) | DK1392830T3 (de) |
| EA (1) | EA005769B1 (de) |
| ES (1) | ES2251610T3 (de) |
| IL (2) | IL157800A0 (de) |
| MX (1) | MXPA03008110A (de) |
| SI (1) | SI1392830T1 (de) |
| UA (1) | UA79235C2 (de) |
| WO (1) | WO2002101049A2 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE500267T1 (de) | 2003-07-21 | 2011-03-15 | Transgene Sa | Multifunktionelle cytokine |
| DE602004031341D1 (de) | 2003-07-21 | 2011-03-24 | Transgene Sa | Multifunktionelle cytokine |
| DK1689777T3 (da) * | 2003-11-05 | 2007-06-11 | Ares Trading Sa | Fremgangsmåde til oprensning af il18-bindende protein |
| WO2005097998A2 (en) * | 2004-03-31 | 2005-10-20 | Regeneron Pharmaceuticals, Inc. | Il-18 specific polypeptides and therapeutic uses thereof |
| AU2006254103B2 (en) | 2005-06-03 | 2012-09-06 | Ares Trading S.A. | Production of recombinant IL-18 binding protein |
| AU2006256763B2 (en) | 2005-06-10 | 2012-08-02 | Ares Trading S.A. | Process for the purification of IL-18 binding protein |
| CN101177454B (zh) * | 2007-05-09 | 2010-09-22 | 郑骏年 | Il-18突变体多肽及制备及用途 |
| WO2012078936A2 (en) * | 2010-12-10 | 2012-06-14 | Glaxosmithkline Llc | Methods to produce a purified peptide chain fraction |
| IL272635B2 (en) * | 2017-09-06 | 2024-02-01 | Univ Yale | Variants of interleukin-18 and methods of use |
| US12029778B2 (en) | 2019-05-13 | 2024-07-09 | Yale University | Interleukin-18 mimics and methods of use |
| JP2021170968A (ja) * | 2020-04-22 | 2021-11-01 | 国立大学法人 長崎大学 | マウスｉｌ−１８の製造方法及びそのための組換えｄｎａ |
| CA3189327A1 (en) * | 2020-08-19 | 2022-02-24 | Vijaya Raghavan PATTABIRAMAN | Modified il-18 polypeptides and uses thereof |
| JP2023550545A (ja) | 2020-11-02 | 2023-12-01 | シムハ・アイエル－１８・インコーポレイテッド | インターロイキン－１８バリアントおよび使用の方法 |
| JP7812094B2 (ja) * | 2021-02-10 | 2026-02-09 | 国立大学法人 長崎大学 | 新規ヒトインターロイキン－１８変異体及びその用途 |
| US20230146665A1 (en) | 2021-07-27 | 2023-05-11 | Xencor, Inc. | Il-18-fc fusion proteins |
| JP7849832B2 (ja) | 2021-08-06 | 2026-04-22 | 国立大学法人 長崎大学 | がんの治療剤 |
| WO2023056193A2 (en) * | 2021-09-29 | 2023-04-06 | Chimera Bioengineering, Inc. | Il-18 variants and uses thereof |
| WO2023118497A1 (en) * | 2021-12-22 | 2023-06-29 | Pieris Pharmaceuticals Gmbh | Novel il-18 variants |
| AU2023226005A1 (en) | 2022-02-23 | 2024-08-29 | Bright Peak Therapeutics Ag | Activatable il-18 polypeptides |
| CA3244053A1 (en) * | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | MODIFIED IL-18 POLYPEPTIDES |
| AU2023226512A1 (en) | 2022-02-23 | 2024-08-29 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
| WO2024044780A1 (en) * | 2022-08-26 | 2024-02-29 | Sutro Biopharma, Inc. | Interleukin-18 variants and uses thereof |
| WO2024102693A2 (en) | 2022-11-07 | 2024-05-16 | Xencor, Inc. | Il-18-fc fusion proteins |
| WO2025085447A1 (en) | 2023-10-17 | 2025-04-24 | Xencor, Inc. | Pd-1 targeted il18-fc fusion proteins |
| US12134635B1 (en) | 2023-12-29 | 2024-11-05 | Sonnet BioTherapeutics, Inc. | Interleukin 18 (IL-18) variants and fusion proteins comprising same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
| TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
| IL129427A0 (en) | 1999-04-13 | 2000-02-17 | Yeda Res & Dev | Preparation of biologically active molecules |
-
2002
- 2002-03-08 WO PCT/IB2002/002344 patent/WO2002101049A2/en not_active Ceased
- 2002-03-08 CN CNB02809803XA patent/CN100503829C/zh not_active Expired - Lifetime
- 2002-03-08 CA CA2438851A patent/CA2438851C/en not_active Expired - Lifetime
- 2002-03-08 AT AT02758668T patent/ATE315647T1/de active
- 2002-03-08 SI SI200230280T patent/SI1392830T1/sl unknown
- 2002-03-08 MX MXPA03008110A patent/MXPA03008110A/es active IP Right Grant
- 2002-03-08 IL IL15780002A patent/IL157800A0/xx unknown
- 2002-03-08 JP JP2003503799A patent/JP2004530432A/ja active Pending
- 2002-03-08 EP EP02758668A patent/EP1392830B1/de not_active Expired - Lifetime
- 2002-03-08 EA EA200300987A patent/EA005769B1/ru not_active IP Right Cessation
- 2002-03-08 AU AU2002324249A patent/AU2002324249B2/en not_active Expired
- 2002-03-08 ES ES02758668T patent/ES2251610T3/es not_active Expired - Lifetime
- 2002-03-08 US US10/094,153 patent/US7524488B2/en not_active Expired - Lifetime
- 2002-03-08 KR KR1020037011581A patent/KR100862136B1/ko not_active Expired - Lifetime
- 2002-03-08 BR BR0207933-0 patent/BRPI0207933B8/pt not_active IP Right Cessation
- 2002-03-08 DE DE60208692T patent/DE60208692T2/de not_active Expired - Lifetime
- 2002-03-08 DK DK02758668T patent/DK1392830T3/da active
- 2002-08-03 UA UA2003109084A patent/UA79235C2/uk unknown
-
2003
- 2003-09-08 IL IL157800A patent/IL157800A/en unknown
-
2009
- 2009-03-16 US US12/404,458 patent/US7875709B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004530432A (ja) | 2004-10-07 |
| WO2002101049A2 (en) | 2002-12-19 |
| KR100862136B1 (ko) | 2008-10-09 |
| MXPA03008110A (es) | 2003-12-12 |
| CN1764723A (zh) | 2006-04-26 |
| WO2002101049A3 (en) | 2003-12-18 |
| EA200300987A1 (ru) | 2004-02-26 |
| BRPI0207933B8 (pt) | 2021-05-25 |
| US7524488B2 (en) | 2009-04-28 |
| US7875709B2 (en) | 2011-01-25 |
| BRPI0207933B1 (pt) | 2020-11-24 |
| UA79235C2 (en) | 2007-06-11 |
| EP1392830B1 (de) | 2006-01-11 |
| IL157800A0 (en) | 2004-03-28 |
| HK1084151A1 (zh) | 2006-07-21 |
| EA005769B1 (ru) | 2005-06-30 |
| IL157800A (en) | 2009-08-03 |
| CA2438851C (en) | 2011-07-26 |
| KR20030088448A (ko) | 2003-11-19 |
| AU2002324249B2 (en) | 2007-04-05 |
| BR0207933A (pt) | 2004-03-02 |
| US20020169291A1 (en) | 2002-11-14 |
| CA2438851A1 (en) | 2002-12-19 |
| US20090286855A1 (en) | 2009-11-19 |
| SI1392830T1 (sl) | 2006-06-30 |
| DE60208692T2 (de) | 2006-07-13 |
| CN100503829C (zh) | 2009-06-24 |
| DE60208692D1 (de) | 2006-04-06 |
| EP1392830A2 (de) | 2004-03-03 |
| ES2251610T3 (es) | 2006-05-01 |
| DK1392830T3 (da) | 2006-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE315647T1 (de) | Interleukin -18 mutantenproteine, deren herstellung und verwendung | |
| ATE449840T1 (de) | Alpha-amylasevariante mit veränderten eigenschaften | |
| EP1649006A4 (de) | Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon | |
| DE602004013372D1 (de) | Il-7-fusionsproteine mit antikörperportionen, deren herstellung und deren verwendung | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| AU2002367818A1 (en) | Ordered biological nanostructures formed from chaperonin polypeptides | |
| ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
| ATE490311T1 (de) | Mutanten der alpha-amylase | |
| WO2002102976A3 (en) | Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 | |
| CY1109593T1 (el) | Παραγωγα 12,13-κυκλοπροπανο εποθιλονης | |
| DE50208918D1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
| DE60235547D1 (de) | En daraus, deren herstellung und verwendung | |
| ATE319814T1 (de) | Luciferase, fluoreszenzproteine, für luciferase und fluoreszenzproteine kodierend nukleinsaüre und ihre verwendung in der diagnose, hoch- durchsatz screeningsverfahren | |
| WO2003050283A3 (en) | A structure for presenting desired peptide sequences | |
| ATE359291T1 (de) | Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna | |
| DE69631516D1 (de) | Säugtieren Kalikanalfamilie, deren Klonierung und Anwendung für Drogenscreening | |
| ATE324446T1 (de) | Mutante formen von etxb und ctxb und ihre verwendung als träger | |
| ATE335824T1 (de) | Isolierte luziferasen sowie deren verwendung | |
| ATE339474T1 (de) | 1:2 metallkomplexfarbstoffe, deren zusammensetzungen, deren herstellung und deren verwendung | |
| DK1005532T3 (da) | Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf | |
| ATE454401T1 (de) | Il-18bp promoter herstellung und verwendung | |
| DE60213827D1 (de) | Antikörper gegen Caspase-8, ihre Herstellung und Verwendung | |
| WO2004111196A3 (en) | Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase | |
| ATE377066T1 (de) | 3-isopropyl-1-methylcyclopentylderivate und deren verwendung bei riechstoffanwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1392830 Country of ref document: EP |